SCHEMBL30249

SCHEMBL30249

C=CC(OC(C=C)C(=O)O)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
BLM P54132 1/20 0.31
SLC6A3 Q01959 1/20 0.31
MEN1 O00255 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4073772 0.87 TSHR (0.30) LMNATSHR
SCHEMBL15118233 0.81
SCHEMBL9302328 0.78
SCHEMBL9603236 0.78
SCHEMBL2136985 0.78
SCHEMBL1489551 0.78 LMNA (0.32) LMNA
SCHEMBL1489552 0.78 LMNA (0.32) LMNA
SCHEMBL296923 0.78
SCHEMBL9651274 0.78
SCHEMBL8642637 0.78 TDP1 (0.34) SLC6A2SLC6A4BLMSLC6A3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1746 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150943-A1 NONWOVEN GLUCAN WEBS NUTRITION & BIOSCIENCES USA 4 INC (US) 2024-05-09 US claimed
US-20240044069-A1 METHOD FOR DECOLORING OF A TEXTILE MATERIAL SODRA SKOGSAGARNA EKONOMISK FORENING (SE) 2024-02-08 US claimed
EP-4301570-A1 METHOD FOR DECOLORING OF A TEXTILE MATERIAL Södra Skogsägarna ekonomisk förening (SE) 2024-01-10 EP claimed
US-11802356-B2 Nonwoven glucan webs Nutrition & Biosciences USA 4, Inc. (US) 2023-10-31 US claimed
CN-116917103-A Method for decolorizing textile materials 瑟德拉斯科格萨加纳经济学会 2023-10-20 CN claimed
US-11759456-B2 Pharmaceutical composition KOWA COMPANY, LTD. (JP) 2023-09-19 US claimed
US-20230190712-A1 PHARMACEUTICAL COMPOSITION KOWA COMPANY, LTD. (JP) 2023-06-22 US claimed
US-11667898-B2 Production and use of phosphoethanolamine cellulose and derivatives THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2023-06-06 US claimed
US-11384163-B2 Alkali metal salt of carboxyalkyl ether of tamarind gum with improved composition TANNA, Raj Mahendra (IN) 2022-07-12 US claimed
US-20210403608-A1 ALKALI METAL SALT OF CARBOXYALKYL ETHER OF TAMARIND GUM WITH IMPROVED COMPOSITION TANNA RAJ MAHENDRA (IN) 2021-12-30 US claimed
WO-1989002900-A1 POLYSACCHARIDES FROM THE ENDOSPERM OF SEEDS OF PROSOPIS JULIFLORA, PROCESS FOR EXTRACTING THEM, AND THEIR USE DIAMALT AKTIENGESELLSCHAFT (DE) 1989-04-06 WO claimed
US-4745184-A SHEAR, FLAKING, CRUSHING, DEPOLYMERIZATION DIAMALT AG (DE) 1988-05-17 US claimed
US-4606771-A Enteric coating liquid KOHJIN CO., LTD. (JP) 1986-08-19 US claimed
EP-0070535-B1 PROCESS FOR THE PURIFICATION OF ESTERS HOECHST AKTIENGESELLSCHAFT (DE) 1985-07-03 EP claimed
EP-0140044-A2 Process to avoid the formation of tartaric acid in beverages HOECHST AKTIENGESELLSCHAFT (DE) 1985-05-08 EP claimed
EP-0135829-A2 Enteric coating liquid Kohjin Co., Ltd. (JP) 1985-04-03 EP claimed
US-4452639-A THICKENING AGENTS CELANESE CORPORATION (US) 1984-06-05 US claimed
EP-0070535-A1 Process for the purification of esters HOECHST AKTIENGESELLSCHAFT (DE) 1983-01-26 EP claimed
US-4272414-A AMMONIUM SULFATE, CARBOXYALKYL OR HYDROXYALKYL ETHER OF A POLYGALACTOMANNAN MONSANTO COMPANY (US) 1981-06-09 US claimed
US-4144093-A SEQUESTERING CALCIUM IONS, FILTRATION, CIRCULATION HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1979-03-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230190712-A1 PHARMACEUTICAL COMPOSITION PEX3, GYS2, PMM2 LMNA 1730/4885SLC6A2 3247/4885SLC6A4 2910/4885
US-11759456-B2 Pharmaceutical composition PEF1, FIBP, F2 LMNA 1789/4885SLC6A2 2975/4885SLC6A4 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.